Systemic manifestations of Parvovirus B19 infections;Manifestations systémiques des infections à Parvovirus B19

Revue de Medecine Interne

Volumn 25, Issue 10, 2004, Pages 740-751

  Seve P ^a   Ferry, T ^a   Charhon, A ^a   Calvet, A ^b   Broussolle, C ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Lupus; Lupus erythematosus; Parvovirus B19; Vascularites; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR;

ARTHRALGIA; ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; ERYTHEMA INFECTIOSUM; FETUS HYDROPS; HEMOLYTIC ANEMIA; HUMAN; PARVOVIRUS; POLYARTHRITIS; RASH; RHEUMATOID ARTHRITIS; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VIRUS INFECTION; VIRUS VIRULENCE;

EID: 4744342544     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.02.026     Document Type: Short Survey

References (104)

1. Cossart Y.E., Field A.M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. i:1975;72-73
2. Pattison J.R., Jones S.E., Hodgson J., Davis L.R., White J.M., Stroud C.E., et al. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancet. i:1981;664-665
3. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L., et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet. i:1983;1378
4. Bültmann B.D., Klingel K., Sotlar K., Bock T., Kandolf R. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch. 442:2003;8-17
5. Anderson M.J., Khousam M.N., Maxwell D.J., Gould S.J., Happerfield L.C., Smith W.J. Human parvovirus B19 and hydrops fetalis. Lancet. i:1988;535
6. Labau E., Bonnet E., Alric L., Massip P. Infection par le Parvovirus B19. Nouvelles approches physiopathologiques. Presse Med. 25:1996;162-166
7. Reid D.M., Brown T., Reid T.M.S., Rennie J.A.N. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet. i:1985;422-425
8. White D.G., Mortimer P.P., Blake D.R., Woolf A.D., Cohen B.J., Bacon P.A. Human parvovirus arthropathy. Lancet. i:1985;419-421
9. Karmochkine M. Infection humaine par le Parvovirus B19. Rev Méd Interne. 16:1995;905-912
10. Modrow S., Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris. 50:2002;326-331
11. Meyer O. Parvovirus B19 and autoimmune diseases. Joint Bone Spine. 70:2003;6-11
12. Woolf A.D., Campion G.V., Chishick A., Wise S., Cohen B.J., Klouda B.T., et al. Clinical manifestations of human parvovirus B19 in adults. Arch Int Med. 149:1989;1153-1156
13. Wendling D., Lorge J.F., Kremer P. Les manifestations rhumatologiques de l'infection à Parvovirus B19. Presse Med. 24:1995;233-236
14. Etienne A., Harms M. Manifestations cutanées de l'infection à Parvovirus B19. Presse Med. 25:1996;1162-1165
15. Harel L., Straussberg I., Zeharia A., Praiss D., Amir J. Papular purpuric rash due to Parvovirus B19 with distribution on the distal extremities and the face. Clin Infect Dis. 35:2002;1158-1161
16. Harel L., Straussberg R., Rudich H., Cohen A.H., Amir J. Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes. Clin Infect Dis. 30:2000;500-503
17. Serjeant G.R., Serjeant B.E., Thomas P.W., Anderson M.J., Patou G., Pattison J.R. Human parvovirus infection in homozygous sickle cell disease. Lancet. 341:1993;1237-1240
18. Saarinen U.M., Chorba T.L., Tattersall P., Young N.S., Anderson L.J., Palmer E., et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood. 67:1986;1411-1417
19. Kurtzman G.J., Ozawa K., Cohen B., Hanson G., Oseas R., Young N.S. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med. 317:1987;287-294
20. Yoto Y., Kudoh T., Suzuki N., Matsunaga Y., Chiba S. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol. 90:1993;8-12
21. Nour B., Green M., Michaels M., Reyes J., Tzakis A., Gartner J.C., et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation. 56:1993;835-838
22. Barah F., Vallely P.J., Cleator G.M., Kerr J.R. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol. 13:2003;185-199
23. Cathébras P., Robert F., Guglielminotti C., Bonnevial L., Rousset H. Primo-infection à parvovirus B19 chez l'immunocompétent : variété d'expression clinique et biologique. Rev Méd Interne. 21:2000;324-329
24. Wierenga K.J., Pattison J.R., Brink N., Griffiths M., Miller M., Shah D.J., et al. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet. 346:1995;475-476
25. Nakazawa T., Tomosugi N., Sakamoto K., Asaka M., Yuri T., Ishikawa I., et al. Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis. 35:2000;E31
26. Barbiano di Belgiojoso G., Ferrario F., Landriani N. Virus-related glomerular diseases: histological and clinical aspects. J Nephrol. 15:2002;469-479
27. Lefrère J.J., Courouce A.M., Kaplan C. Parvovirus and idiopathic thrombocytopenia purpura. Lancet. 1:1989;279
28. Muir K., Todd W.T., Watson W.H., Fitzsimons E. Viral-associated haemophagocytosis with parvovirus-B19-related pancytopenia. Lancet. 339:1992;1139-1140
29. Yoto Y., Kudoh T., Haseyama K., Susuki N., Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet. 347:1996;868-869
30. Sasaki T., Takahashi Y., Yoshiniga K., Sugamura K., Shiraishi H. An association between human parvovirus B-19 infection and auto-antibody production. J Rheumatol. 16:1989;708-709
31. Soloninka C.A., Anderson M.J., Laskin C.A. Anti-I and antilymphocyte during acute infection with human parvovirus B19. J Rheumatol. 16:1989;777-781
32. Kerr J.R., Boyd N. Autoantibodies following parvovirus B19 infection. J Infect. 32:1996;41-47
33. Loizou S., Cazabon J.K., Walport M.J., Dereck T., So A.K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 40:1997;103-108
34. Von Landenberg, Lehmann H.W., Knöll A., Dorsch S., Modrow S. Antiphospholipid antibodies in pediatric and adult patients are associated with parvovirus B19 infection. Arthritis Rheum. 48:2003;1939-1947
35. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 for the classification of rheumatoid arthritis. Arthritis Rheum. 25:1988;1271-1277
36. Tyndall A., Jelk W., Hirsch H.H. Parvovirus B19 and erosive polyarthritis. Lancet. 343:1994;480-481
37. Lefrere J.J., Meyer O., Menkes C.J., Beaulieu M.J., Couroucé A.M. Human parvovirus and rheumatoid arthritis. Lancet. i:1985;982
38. Oguz F., Akdeniz C., Unüvar E., Kücükbasmaci O., Sidal M. Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis. J Paediatr Child Health. 38:2002;358-362
39. Tovari E., Mezey I., Hedman K., Czirjak L. Self limiting-like symptoms in patients with parvovirus B19 infection. Ann Rheum Dis. 61:2002;662-663
40. Kalt M., Gertner E. Antibodies to β2-Glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in Parvovirus B19 infection. J Rheumatol. 28:2001;2335-2336
41. Narvaez Garcia F.J., Domingo-Domènech E., Castro-Bohorquez F.J., Biosca M., Garcia-Quintana A., et al. Lupus like presentation of parvovirus B19 infection. Am J Med. 111:2001;573-574
42. Trapani S., Ermini M., Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum. 28:1999;319-325
43. Vigeant P., Menard H.A., Boire G. Chronic modulation of the autoimmune response following parvovirus B19. J Rheumatol. 21:1994;1165-1167
44. Kalish R.A., Knopf A.N., Gary G.W., Canoso J.J. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol. 19:1992;169-171
45. Nesher G., Osborn T.G., Moore T.L. Parvovirus B19 infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum. 24:1995;297-303
46. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angiodema, C1 esterase inhibitor, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol. 23:1996;1180-1185
47. Diaz F., Collazos J., Mendoza F., De la Viuda J.M., Cazallas J., Urkijo J.C., et al. Systemic lupus erythematosus associated with acute parvovirus B19 infection. Clin Microbiol Infect. 8:2002;115-117
48. Cope A.P., Jones A., Brozovic M., Shafi M.S., Maini R.N. The possible induction of systemic lupus erythematosus by human parvovirus. Ann Rheum Dis. 51:1992;803-804
49. Nigro G., Piazze J., Taliani G., Mazzocco M., Cassinotti P., Cosmi E.V. Postpartum lupus erythematosus associated with parvovirus B19 infection. J Rheumatol. 24:1997;968-970
50. Gran J.T., Johnse V., Myklebust G., Nordba S. The variable clinical picture of arthritis induced by human parvovirus B19. Scand J Rheumatol. 24:1995;174-179
51. Hemauer A., Becklenlehner K., Wolf H., Lang B., Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematosus in a female patient. J Clin Virol. 14:1999;73-77
52. Meyer O., Kahn M.F., Grossin M. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus. 1:1991;37-41
53. Chassagne Ph., Mejjad O., Gourmelen O., Moore N., Le Loet X., Deshayes P. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. Br J Rheumatol. 32:1993;158-159
54. Glickstein S.L. Lupus-like presentation of human parvovirus B19 infection. J Rheumatol. 19:1992;1253
55. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:1997;1725
56. Hsu T.C., Tsay G.J. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology. 40:2001;152-157
57. Bengtsson A., Widell A., Elmstahl S., Sturfelt G. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis. 59:2000;64-66
58. Lewkonia R.M., Horne D., Dawood M.R. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis. 21:1995;430-432
59. Crowson A.N., Magro C.M., Dawood M.R. A cause role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol. 27:2000;505-515
60. Chevrel G., Calvet A., Belin V., Miossec P. Dermatomyositis assiated with the presence of parvovirus B19 ADN in muscle. Rheumatology. 39:2000;1037-1039
61. Bohan A., Peter J.B. Polymyositis and dermatomyositis: first of two parts. N Engl J Med. 292:1975;344-347
62. Chevrel G., Borsotti J.P., Miossec P. Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow-up study. Rheumatology. 42:2003;349-352
63. Ramos-Casals M., Cervera R., Garcia-Carrasco M., Vidal J., Tréjo O., Jimenez S., et al. Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome. Semin Arthritis Rheum. 29:2000;373-378
64. De Stefano R., Manganelli S., Frati E., Selvi E., Azzi A., Zakrzewska K., et al. No association between human parvovirus B19 infection and Sjögren's syndrome. Ann Rheum Dis. 62:2003;86-87
65. De Re V., De Vita S., Battistella V., Marzotto A., Libra M., Ferraccioli G., et al. Absence of human parvovirus B19 ADN in myoepithelial sialadenitis of primary Sjögren's syndrome. Ann Rheum Dis. 61:2002;855-856
66. Ferri C., Zakrzewska K., Longombardo G., Giuggioli D., Storino F.A., Pasero G., et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol. 17:1999;718-720
67. Ferri C., Giuggioli D., Sebastiani M., Panfilo S., Zakrzewska K., Azzi A. Parvovirus B19 infection of cultured skin fibroblast from systemic sclerosis patients: comment on the article by Ray et al. Arthritis Rheum. 46:2002;2262-2263
68. Nikkari S., Mertsola J., Korvenranta H., Vainionpää R., Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum. 11:1994;1707-1710
69. Corman L.C., Staud R. Association of Wegener's granulomatosis and parvovirus B19 infection : comment on the concise communication by Nikkari et al. Arthritis Rheum. 38:1995;1174-1175
70. Corman L.C., Dolson D.J. Polyarteritis nodosa and parvovirus B19 infection. Lancet. 339:1992;491
71. Finkel T.H., Torok T.J., Ferguson F.J., Durigon E.L., Zaki S.R., Leung D.Y., et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or etiological agent? Lancet. 343:1994;1255-1258
72. Zulian F., Costantini C., Montesco M.C., Shiavon F., Zacchello F. Successful treatment of gangrene in systemic necrotizing vasculitis with Iloprost. Br J Rheumatol. 37:1998;228-230
73. Viguier M., Guillevin L., Laroche L. Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globuline. N Engl J Med. 344:2001;1481-1482
74. Gaches F., Loustaud V., Vidal E., Delaire L., Guiard-Schmid J.B., Lavoine E., et al. Périartérite noueuse et infection par le parvovirus B19. Rev Méd Interne. 14:1993;323-325
75. Durst R., Goldschmidt N., Ben Yehuda A. Parvovirus B19 infection associated with myelosuppression simultaneously and cutaneous polyarteritis nodosa. Rheumatology. 41:2002;1210-1212
76. Lefrere J.J., Couroucé A.M., Muller J.Y., Clark M., Soulier J.P. Human parvovirus and purpura (letter). Lancet. 2:1985;730
77. Mortimer P.P., Cohen B.J., Rossiter M.A., Fairhead S.M., Rahman A.F. Human parvovirus and purpura (letter). Lancet. 2:1985;730-731
78. Lefrere J.J., Courouce A.M., Soulier J.P., Cordier M.P., Guesne-Girault M.C., Polonovski C., et al. Henoch-Schönlein purpura and human parvovirus infection. Pediatrics. 78:1986;183-184
79. Schwarz T.F., Brun R., Schroder S., Wiersbitzky S., Roggendorff M. Human parvovirus infection associated with vascular purpura vasculitis. Infection (Munchen). 17:1986;170-171
80. Watanabe T., Yoshihiko O. Henoch-Schönlein purpura associated with human parvovirus B19 infection. Pediatrics International. 42:2000;94-96
81. Quémeneur T., Lambert M., Fauchais A.L., Queyrel V., Michon-Pasturel U., Hachulla E., et al. Purpura rhumatoïde de l'adulte et infection à parvovirus B19 : association fortuite ou vascularite induite par le parvovirus B19 ? Rev Méd Interne. 23:2002;77-80
82. Cioc A.M., Sedmak D.D., Nuovo G.J., Dawood M.R., Smart G., Nagro C.M. Parvovirus B19 associated adult Henoch Schönlein purpura. J Cutan Pathol. 29:2002;602-607
83. Véraldi S., Rizzitelli G. Henoch-Schönlein purpura and human parvovirus infection. Dermatology (Basel). 189:1994;213-214
84. Delannoy D., Balquet M.H., Savinel P. Vascularite avec cryoglobuline mixte au cours d'une infection par le parvovirus humain B19. Presse Méd. 22:1993;175
85. Staud R., Corman L.C. Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis. 22:1996;1123
86. Nikkari S., Vainionpää R., Toivanen P., Gross W., Mistry N., Csernok E., et al. Reply. Arthritis Rheum. 38:1995;1175
87. Leruez-Ville M., Laugé A., Morinet F., Guillevin L., Deny P. Polyarteritis nodosa and parvovirus B19. Lancet. 344:1994;263-264
88. Ferguson P.J., Saulsbury F.T., Dowell S.F., Török T.J., Erdman D.D., Anderson L.J. Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura. Arthritis Rheum. 39:1996;880-882
89. Challine-Lehmann D., Mauberquez S., Pawtolsky J., Rostoker G. Parvovirus B19 and Henoch-Schönlein purpura in adults. Nephron. 83:1999;172
90. Gabriel S.E., Espy M., Erdman D.D., Bjornsson J., Smith T.F., Hunder G.G. The role of parvovirus B19 in pathogenesis of giant cell arteritis. Arthritis Rheum. 42:1999;1255-1258
91. Salvarani C., Farnetti E., Casali B., Nicoli D., Wenlan L., Bajocchi G.L., et al. Detection of parvovirus B19 ADN by polymerase chain reaction in giant cell arteritis. Arthritis Rheum. 42:2002;3099-3101
92. Hemauer A., Modrow S., Georgi J., Helmke K., Vaith P., Lang B., et al. There is no association between polymyalgia rheumatica and acute parvovirus B19 infection. Ann Rheum Dis. 58:1999;657
93. Nigro G., Zerbini M., Krystofiak A., Gentilomi G., Porcaro M.A., Mango T., et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet. 343:1994;1260-1261
94. Yoto Y., Kudoh T., Haseyama K., Susuki N., Chiba S., Matsunaga Y. Human parvovirus B19 infection in Kawasaki disease. Lancet. 344:1994;58-59
95. Cohen B.J. Human parvovirus B19 infection in Kawasaki disease. Lancet. 344:1994;59
96. Pouchot J., Quakil H., Debin M.L., Vinceneux P. Adult Still's disease associated with acute human parvovirus B19 infection (letter). Lancet. 347:1996;868-869
97. Longo G., Luppi M., Bertesi M., Ferrara L., Torelli G., Emilia G. Still's disease, severe thrombocytopenia, and acute hepatitis associated with acute parvovirus B19 infection. Clin Infect Dis. 26:1998;994-995
98. Blidi M., Gatfossé M., Barjonet G. Maladie de Still associée à une infection aiguë par le Parvovirus B19, survenant au cours de la grossesse. Ann Med Interne. 147:1996;518-519
99. Godeau B., Palazzo E., Morinet F., Delplanche M., Deforge L., Schaeffer A., et al. Is Still's disease associated with parvovirus B19 infection? Lancet. 345:1994;59-60
100. Kok R.H., Wolfhagen J.H., Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis. 32:2001;311-312
101. Sasaki T., Murai C., Muryoi T., Takhashi Y., Munakata Y., Sugamura K., et al. Persistent infection of human parvovirus B19 in a normal subject. Lancet. 346:1995;851
102. Dorsch S., Liebisch G., Kaufmann B., von Landenberg P., Hoffmann J.H., Drobnik W., et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 76:2002;2014-2018
103. Mitchell A. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukine-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J Med Virol. 67:2002;267-274
104. Fu Y., Ishii K.K., Munakata Y., Saitoh T., Kaku M., Sasaki T. Regulation of tumor necrosis factor by Human B19 NS1 through activation of AP-1 and AP-2. J Virol. 76:2002;5395-5403